Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma.

Maximov V, Chen Z, Wei Y, Robinson MH, Herting CJ, Shanmugam NS, Rudneva VA, Goldsmith KC, MacDonald TJ, Northcott PA, Hambardzumyan D, Kenney AM.

Nat Commun. 2019 Jun 3;10(1):2410. doi: 10.1038/s41467-019-10458-9.

2.

Reactive Oxygen Species Signaling Promotes Hypoxia-Inducible Factor 1α Stabilization in Sonic Hedgehog-Driven Cerebellar Progenitor Cell Proliferation.

Eyrich NW, Potts CR, Robinson MH, Maximov V, Kenney AM.

Mol Cell Biol. 2019 Apr 2;39(8). pii: e00268-18. doi: 10.1128/MCB.00268-18. Print 2019 Apr 15.

PMID:
30692272
3.

Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Bielack S, Abecassis N, Aro HT, Bauer S, Biagini R, Bonvalot S, Boukovinas I, Bovee JVMG, Brennan B, Brodowicz T, Broto JM, Brugières L, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Dhooge C, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gaspar N, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hecker-Nolting S, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kager L, Kasper B, Kopeckova K, Krákorová DA, Ladenstein R, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Morland B, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Strauss SJ, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee, PaedCan and ERN EURACAN.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv79-iv95. doi: 10.1093/annonc/mdy310. No abstract available.

4.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv268-iv269. doi: 10.1093/annonc/mdy321. No abstract available.

5.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Aro HT, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, van der Graaf WTA, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv267. doi: 10.1093/annonc/mdy320. No abstract available.

6.

Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, Van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv68-iv78. doi: 10.1093/annonc/mdy095. No abstract available.

PMID:
29846513
7.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Casali PG, Abecassis N, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Brodowicz T, Broto JM, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dileo P, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Ferrari S, Frezza AM, Gasperoni S, Gelderblom H, Gil T, Grignani G, Gronchi A, Haas RL, Hannu A, Hassan B, Hohenberger P, Issels R, Joensuu H, Jones RL, Judson I, Jutte P, Kaal S, Kasper B, Kopeckova K, Krákorová DA, Le Cesne A, Lugowska I, Merimsky O, Montemurro M, Pantaleo MA, Piana R, Picci P, Piperno-Neumann S, Pousa AL, Reichardt P, Robinson MH, Rutkowski P, Safwat AA, Schöffski P, Sleijfer S, Stacchiotti S, Sundby Hall K, Unk M, Van Coevorden F, Van der Graaf W, Whelan J, Wardelmann E, Zaikova O, Blay JY; ESMO Guidelines Committee and EURACAN.

Ann Oncol. 2018 Oct 1;29(Supplement_4):iv51-iv67. doi: 10.1093/annonc/mdy096. No abstract available.

PMID:
29846498
8.

Antihypertensive medication adherence and blood pressure control among central Alabama veterans.

Piercefield EW, Howard ME, Robinson MH, Kirk CE, Ragan AP, Reese SD.

J Clin Hypertens (Greenwich). 2017 May;19(5):543-549. doi: 10.1111/jch.12953. Epub 2016 Dec 5.

9.

A gemcitabine sensitivity screen identifies a role for NEK9 in the replication stress response.

Smith SC, Petrova AV, Madden MZ, Wang H, Pan Y, Warren MD, Hardy CW, Liang D, Liu EA, Robinson MH, Rudra S, Wang J, Ehdaivand S, Torres MA, Wang Y, Yu DS.

Nucleic Acids Res. 2014 Oct;42(18):11517-27. doi: 10.1093/nar/gku840. Epub 2014 Sep 12.

10.

Second generation benzofuranone ring substituted noscapine analogs: synthesis and biological evaluation.

Mishra RC, Karna P, Gundala SR, Pannu V, Stanton RA, Gupta KK, Robinson MH, Lopus M, Wilson L, Henary M, Aneja R.

Biochem Pharmacol. 2011 Jul 15;82(2):110-21. doi: 10.1016/j.bcp.2011.03.029. Epub 2011 Apr 8.

11.

Common genetic changes in leiomyosarcoma and gastrointestinal stromal tumour: implication for ataxia telangiectasia mutated involvement.

Ul-Hassan A, Sisley K, Hughes D, Hammond DW, Robinson MH, Reed MW.

Int J Exp Pathol. 2009 Oct;90(5):549-57. doi: 10.1111/j.1365-2613.2009.00680.x.

12.

From small acorns--developing a laparoscopic colorectal surgical service.

Smith JK, Acheson AG, Simpson JA, Stewart J, Beckingham IJ, Gornall CB, Williams JP, Robinson MH, Maxwell-Armstrong CA.

Ann R Coll Surg Engl. 2008 Oct;90(7):606-11. doi: 10.1308/003588408X318110.

13.

Re: The impact of published recommendations on the management of penetrating abdominal injury (Br J Surg 2008; 95: 515-521).

Watson NF, Coleman JP, Robinson MH, Maxwell-Armstrong CA.

Br J Surg. 2008 Jul;95(7):930; author reply 930. doi: 10.1002/bjs.6313. No abstract available.

PMID:
18551499
14.

Editorial.

Robinson MH.

Sarcoma. 2000;4(1-2):5. doi: 10.1155/S1357714X00000013. No abstract available.

15.

Case report of uncontrollable pelvic bleeding--managed by a previously unreported method (QuikClot).

Shanmugam V, Robinson MH.

Colorectal Dis. 2009 Feb;11(2):221-2. doi: 10.1111/j.1463-1318.2008.01550.x. Epub 2008 May 3.

PMID:
18462245
16.

Tris interference in IEF and 2-DE.

Smejkal GB, Robinson MH.

Electrophoresis. 2007 May;28(10):1601-6.

PMID:
17447237
17.

Nonrigid image registration for head and neck cancer radiotherapy treatment planning with PET/CT.

Ireland RH, Dyker KE, Barber DC, Wood SM, Hanney MB, Tindale WB, Woodhouse N, Hoggard N, Conway J, Robinson MH.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):952-7. Epub 2007 Apr 18.

18.
19.

Increased protein yields from Escherichia coli using pressure-cycling technology.

Smejkal GB, Robinson MH, Lawrence NP, Tao F, Saravis CA, Schumacher RT.

J Biomol Tech. 2006 Apr;17(2):173-5.

20.

Optimizing localization accuracy in head and neck, and brain radiotherapy.

McJury M, Dyker K, Nakielny R, Conway J, Robinson MH.

Br J Radiol. 2006 Aug;79(944):672-80. Epub 2006 Apr 26.

PMID:
16641422
21.

Simultaneous reduction and alkylation of protein disulfides in a centrifugal ultrafiltration device prior to two-dimensional gel electrophoresis.

Smejkal GB, Li C, Robinson MH, Lazarev AV, Lawrence NP, Chernokalskaya E.

J Proteome Res. 2006 Apr;5(4):983-7.

PMID:
16602706
22.

Perineal resection of a sigmoid tumour presenting as colorectoanal intussusception: report of a case and review of the literature.

Lambrou NA, Dunn WK, Robinson MH.

Int J Colorectal Dis. 2006 Apr;21(3):286-7. Epub 2005 Feb 8. No abstract available.

PMID:
15700152
23.

Effect of the anticoagulant, pindone, on the breeding performance and survival of merino sheep, Ovis aries.

Robinson MH, Twigg LE, Wheeler SH, Martin GR.

Comp Biochem Physiol B Biochem Mol Biol. 2005 Mar;140(3):465-73.

PMID:
15694595
24.

Comparison of fluorescent stains: relative photostability and differential staining of proteins in two-dimensional gels.

Smejkal GB, Robinson MH, Lazarev A.

Electrophoresis. 2004 Aug;25(15):2511-9.

PMID:
15300770
25.

Biochemical and bioengineering analysis of the skin's natural moisturizing factors.

Robinson MH, Wickett RR.

J Cosmet Sci. 2004 Mar-Apr;55(2):211-2. No abstract available.

PMID:
15190893
26.
27.

The impact of the two-week wait scheme for suspected gastrointestinal cancers.

Boulton-Jones JR, Gamble S, Robinson MH, Goddard WP, Long RG, Teahon K.

Clin Med (Lond). 2003 Sep-Oct;3(5):483-4. No abstract available.

28.

An audit of the management of soft tissue sarcoma within a health region in the UK.

Glencross J, Balasubramanian SP, Bacon J, Robinson MH, Reed MW.

Eur J Surg Oncol. 2003 Oct;29(8):670-5.

PMID:
14511616
29.

How often is a positive faecal occult blood test the result of coeliac disease?

Logan RF, Howarth GF, West J, Shepherd K, Robinson MH, Hardcastle JD.

Eur J Gastroenterol Hepatol. 2003 Oct;15(10):1097-100.

PMID:
14501618
30.

Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome.

Lim W, Hearle N, Shah B, Murday V, Hodgson SV, Lucassen A, Eccles D, Talbot I, Neale K, Lim AG, O'Donohue J, Donaldson A, Macdonald RC, Young ID, Robinson MH, Lee PW, Stoodley BJ, Tomlinson I, Alderson D, Holbrook AG, Vyas S, Swarbrick ET, Lewis AA, Phillips RK, Houlston RS.

Br J Cancer. 2003 Jul 21;89(2):308-13.

32.

Psychiatric morbidity and screening for colorectal cancer.

Parker MA, Robinson MH, Scholefield JH, Hardcastle JD.

J Med Screen. 2002;9(1):7-10.

PMID:
11943790
33.

High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial.

Howarth GF, Robinson MH, Jenkins D, Hardcastle JD, Logan RF.

Am J Gastroenterol. 2002 Mar;97(3):690-4.

PMID:
11926210
34.

The role of intensity-modulated radiotherapy in the treatment of parotid tumors.

Bragg CM, Conway J, Robinson MH.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):729-38.

PMID:
11849796
35.

Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques.

Nutting CM, Rowbottom CG, Cosgrove VP, Henk JM, Dearnaley DP, Robinson MH, Conway J, Webb S.

Radiother Oncol. 2001 Aug;60(2):163-72.

PMID:
11439211
36.

Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.

Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, Robinson MH, Logan RF.

Gut. 2001 Jul;49(1):91-6.

37.

The impact of virtual simulation in palliative radiotherapy for non-small-cell lung cancer.

McJury M, Fisher PM, Pledge S, Brown G, Anthony C, Hatton MQ, Conway J, Robinson MH.

Radiother Oncol. 2001 Jun;59(3):311-8.

PMID:
11369073
38.

Selective angiographic catheterisation for jejunal angiodysplasia.

Robinson MH, Hussain SA.

Postgrad Med J. 2001 Mar;77(905):205. No abstract available.

39.

Laparoscopic colorectal cancer surgery.

Maxwell-Armstrong CA, Robinson MH, Scholefield JH.

Am J Surg. 2000 Jun;179(6):500-7. Review.

PMID:
11004341
40.

Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process.

Robinson MH, Rodrigues VC, Hardcastle JD, Chamberlain JO, Mangham CM, Moss SM.

J Med Screen. 2000;7(2):97-8.

PMID:
11002450
41.

Automatic image registration of diagnostic and radiotherapy treatment planning CT head images.

Vaarkamp J, Barber DC, Conway J, Robinson MH.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):225-30.

PMID:
10758328
42.

VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma.

El Helw LM, Lorigan PC, Robinson MH, Coleman RE, Hancock BW.

Int J Oncol. 2000 Apr;16(4):777-82.

PMID:
10717248
43.

Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening.

Mapp TJ, Hardcastle JD, Moss SM, Robinson MH.

Br J Surg. 1999 Oct;86(10):1286-91.

PMID:
10540135
44.

The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer.

Robinson MH, Hardcastle JD, Moss SM, Amar SS, Chamberlain JO, Armitage NC, Scholefield JH, Mangham CM.

Gut. 1999 Oct;45(4):588-92.

45.

Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test.

Moss SM, Hardcastle JD, Coleman DA, Robinson MH, Rodrigues VC.

Int J Epidemiol. 1999 Jun;28(3):386-90.

PMID:
10405838
46.

Should we be screening for colorectal cancer?

Robinson MH, Hardcastle JD.

Br Med Bull. 1998;54(4):807-21. Review.

PMID:
10367416
47.

Primary intracerebral lymphoma: A clinicopathological study of 28 patients.

Hough RE, Smith CM, Nakielny RA, Robinson MH, Jacubowski J, Lorigan PC, Hancock BW.

Int J Oncol. 1999 Apr;14(4):647-52.

PMID:
10087310
48.

Is pre-operative radiotherapy superior to postoperative radiotherapy in the treatment of soft tissue sarcoma?

Robinson MH, Keus RB, Shasha D, Harrison LB.

Eur J Cancer. 1998 Aug;34(9):1309-16. Review. No abstract available.

PMID:
9849411
49.

Localised non-Hodgkin's lymphoma: the Sheffield Lymphoma Group experience (1970-1995).

Dobson LS, Hancock H, Bright N, Robinson MH, Hancock BW.

Int J Oncol. 1998 Dec;13(6):1313-8.

PMID:
9824650
50.

Serum ferritin. Screening test for colorectal cancer?

Scholefield JH, Robinson MH, Bostock K, Brown NS.

Dis Colon Rectum. 1998 Aug;41(8):1029-31; discussion 1031-2.

PMID:
9715161

Supplemental Content

Loading ...
Support Center